drug costs | Citizens Against Government Waste
The WasteWatcher: The Staff Blog of Citizens Against Government Waste

drug costs

Senate Finance Committee Drug Pricing Changes - Market Driven or More Destructive Price Controls?

The healthcare policy community is anxiously waiting to see what kind of pharmaceutical pricing legislation Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) will produce for Medicare and Medicaid drug plans when Congress returns from the Independence Day break.  Will the shallow, but damaging, policy of instituting price controls be utilized or will enhanced competitive private-sector negotiations be allowed to take hold?  Because competition always leads to lower costs and more innovation, Citizens Against Government Waste (CAGW) hopes it is t

House Speaker Pelosi's Bizarre Drug Price Negotiation Plan

Speaker Nancy Pelosi (D-Calif.) is expected to soon release her long-awaited drug pricing proposal.  According to news reports, the plan is expected to require the Department of Health and Human Services (HHS) to directly “negotiate” with pharmaceutical manufacturers for an “acceptable” price for at least 25 drugs that would apply to the entire U.S. market.  If no agreement can be reached, the Government Accountability Office would act as an arbitrator and oversee a dispute resolution.

Adopting Foreign Countries’ Price Controls: A Really Bad Idea

Citizens Against Government Waste (CAGW) was troubled and mystified when the Trump administration issued an advanced notice of proposed rulemaking that would change Medicare Part B reimbursement for outpatient drugs from the Average Sales Price (ASP) plus 6 percent to instead a reimbursement system based on what other countries pay for the same drugs.

President Trump’s Blueprint to Lower Drug Costs: A Lot to Unpack

On Friday, May 11, President Trump released his report on what his administration will do to lower drug costs.

Another Dumb Idea from Democrats on Drug Costs

Today, House Oversight and Government Reform Committee Ranking Member Elijah Cummings (D-Md.), Sen. Patrick Leahy (D-Vt.), Sen. Bernie Sanders (I-Vt.), Rep. Lloyd Doggett (D-Texas) and Rep. Peter Welch (D-Vt.), held a press conference to engage in their usual screed  against pharmaceutical companies and provide a “solution” to lower drug costs in Medicare Part D.  Rep.

Sign Up for Email Updates!Click Here!

View Archives

Posts by Author

Posts by Tag

Big Government (152) Obamacare (85) Congress (81) Healthcare (76) Waste (75) Budget (75) Uncategorized (56) Telecommunications (50) Internet (49) Debt (47) Technology (47) Deficit (44)